论文部分内容阅读
帮备口服液(盐酸班布特罗)为新一代长效β2受体激动剂,其药理作用可维持24h,为评价班布特罗治疗儿童支气管哮喘的临床疗效,现将我院哮喘患儿帮备口服液治疗的效果报告如下。1资料与方法1.1对象自2001年9月-2002年6月,我院门诊以及住院就诊的哮喘急性发作患儿80例,均符合支气管哮喘诊断标准。入选患儿均除外以下情况:①治疗前2周内使用激素,24h内应用茶碱;②糖尿病、甲亢、高血压、心肝肾功能不全患儿。采用计算机随机数字分组法将患儿分为治疗组和对照组,二组患儿一般情况见表1。
To prepare oral liquid (bambuterol hydrochloride) is a new generation of long-acting β2 receptor agonist, its pharmacological effects can be maintained for 24h, in order to evaluate the clinical efficacy of bambuterol in children with bronchial asthma, now our hospital asthma children To prepare oral liquid treatment results are as follows. 1 Materials and Methods 1.1 Object From September 2001 to June 2002, 80 cases of acute exacerbation of asthma in our out-patient clinic and hospitalized, all in line with the diagnostic criteria of bronchial asthma. Children were selected except for the following conditions: ① 2 weeks before treatment with hormones, 24h theophylline; ② diabetes, hyperthyroidism, heart and kidney dysfunction in children. Children were divided into treatment group and control group by computer random number grouping method. Table 1 shows the general situation of the two groups of children.